Prosecution Insights
Last updated: April 19, 2026

Jiangsu Hansoh Pharmaceutical Group Co. Ltd.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18558165 SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF RAO, SAVITHA M 1691 Non-Final OA Oct 30, 2023
18555468 HETEROCYCLIC DERIVATIVE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHOWALTER, ALEXANDER KEITH 1629 Non-Final OA Oct 13, 2023
18263091 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF SKOKO III, JOHN JOSEPH 1643 Non-Final OA Jul 26, 2023
18254623 SALT AND CRYSTAL FORM OF NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF HUI, SAN MING R 1627 Non-Final OA May 26, 2023
17875811 PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF PHAN, DOAN THI-THUC 1613 Non-Final OA Jul 28, 2022
17596239 ANTI-B7-H4 ANTIBODY-DRUG CONJUGATE AND MEDICINAL USE THEREOF PUTTLITZ, KARL J 1646 Final Rejection Dec 06, 2021

Managing Jiangsu Hansoh Pharmaceutical Group Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month